April 01, 2025

Uveitis Corner: Biosimilars in Noninfectious Uveitis

This article serves as review on the recent literature comparing outcomes of biosimilars to originator drugs in the treatment of noninfectious uveitis in both pediatric and adult populations.

Retinal Physician

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant

March 28, 2025

Assessing Osteoporosis Risk in Younger Postmenopausal Women

Commonly used tools may fall short in identifying at-risk women, study finds.

Conexiant

March 27, 2025

RA and axSpA Tied to Depression, Anxiety in Large Study

Individuals with autoimmune arthritides are more likely to experience mood and anxiety disorders—even relative to counterparts with other chronic illnesses—according to a national cohort study.

Conexiant

March 27, 2025

Hip Replacement with Few Signs of OA

A study finds that total hip arthroplasty in patients with minimal radiographic osteoarthritis results in high satisfaction but lower functional outcomes, with only 33% achieving a patient-acceptable symptom state.

Conexiant

March 25, 2025

Not All Plant-Based Diets Are Equal

Higher adherence to a healthy plant-based diet linked to lower IBD risk.

Conexiant

March 25, 2025

Not All Plant-Based Diets Are Equal

Higher adherence to a healthy plant-based diet linked to lower IBD risk.

Conexiant

March 24, 2025

Tildrakizumab Shows Lasting Efficacy in Scalp Psoriasis

Tildrakizumab may provide durable response for scalp psoriasis, a phase 3b study found, confirming sustained efficacy and safety through 52 weeks.

Conexiant